Evidence map›Paper›PMID 41889998›Full record

ArticlebioRxiv : the preprint server for biology2026

ChironRNA: Steric Clashes Resolution in RNA Structures via E(3)-Equivariant Diffusion.

Jingyi Li, Jian Wang, Nikolay V Dokholyan

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jingyi LiDepartment of Neuroscience & Experimental Therapeutics, Penn State College of Medicine, Hershey, Pennsylvania, USA.
Jian WangDepartments of Neurology, University of Virginia, Charlottesville, Virginia, USA.
Nikolay V DokholyanDepartments of Neurology, University of Virginia, Charlottesville, Virginia, USA.ORCID 0000-0002-8225-4025

Funding

Nanoscale programming of cellular and physiological phenotypes: EquipmentR35GM134864 · NIGMS · UNIVERSITY OF VIRGINIA · PI Nikolay Dokholyan · 2020 to 2026
$5.2M
NIGMS NIH HHS R35 GM134864
6 · The paper itself

Abstract

Due to the limited resolution of experimental data, many determined RNA structures contain physically implausible geometries, such as severe steric clashes and missing atoms. Resolving these defects during RNA structure refinement remains a fundamental challenge. Structure dictates the function, so the geometric accuracy of RNA structure is critical for understanding biological mechanisms. However, traditional algorithms for correction have limitations because of the complexity of RNA structures. We propose ChironRNA, an all-atom diffusion model with E(3)-equivariant graph neural networks to perform RNA refinement by resolving steric clashes and completing missing atoms. In ChironRNA, we adopt a hierarchical approach, including both an all-atom diffusion model and a coarse-grained diffusion model where each nucleotide is represented by a five-point representation. Our pipeline consists of two stages: a training stage and a generation stage. The diffusion model regenerates clashing nucleotide atoms step by step by removing the noise predicted by EGNN. ChironRNA achieves an 80% clash reduction on more than 80% of the test set. It performs better on structures of less than 200 nucleotides, resulting in a high percentage of cases having over 80% clash reduction rate and 100% atom reconstruction rate. Our results demonstrate that ChironRNA successfully resolves steric clashes and rebuilds missing atoms with high precision, offering a robust solution where traditional fine-tuning or enumerative approaches fail.

Identifiers

PMID41889998
PMCPMC13015368

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.